Furthermore, inhibition of AKT with LY294002 and more specific AKT inhibitor III suppressed secretion of VEGF from breast cancer cells resulting in the decrease of capillary morphogenesis of endothelial cells. The gene discussed is AKT1; the disease is breast carcinoma.